CoChat
Sign Up
Cited by 260Personality Disorders and PsychopathologyMental Health Treatment and AccessTreatment of Major Depression

Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa depression study

Melartin, Tarja K., Rytsala, Heikki J., Leskela, Ulla S., Lestela-Mielonen, Paula S., Sokero, T. Petteri, Isometsa, Erkki T.·2002·The Journal of Clinical Psychiatry
DOI 10.4088/jcp.v63n0207
Open this paper in CoChat — free account

Abstract

BACKGROUND: While numerous studies have documented the high comorbidity of major depressive disorder (MDD) with individual mental disorders, no published study has reported overall current comorbidity with all Axis I and II disorders among psychiatric patients with MDD, nor systematically investigated variations in current comorbidity by sociodemographic factors, inpatient versus outpatient status, and number of lifetime depressive episodes. METHOD: Psychiatric outpatients and inpatients in Vantaa, Finland, were prospectively screened for an episode of DSM-IV MDD, and 269 patients with a new episode of MDD were enrolled in the Vantaa Depression MDD Cohort Study. Axis I and II comorbidity was assessed via semistructured Schedules for Clinical Assessment in Neuropsychiatry, version 2.0, and Structured Clinical Interview for DSM-II-R personality disorders interviews. RESULTS: The great majority (79%) of patients with MDD suffered from 1 or more current comorbid mental disorders, including anxiety disorder (57%), alcohol use disorder (25%), and personality disorder (44%). Several anxiety disorders were associated with specific Axis II clusters, and panic disorder with agoraphobia was associated with inpatient status. The prevalence of personality disorders varied with inpatient versus outpatient status, number of lifetime depressive episodes, and type of residential area, and the prevalence of substance use disorders varied with gender and inpatient versus outpatient status. CONCLUSION: Most psychiatric patients with MDD have at least 1 current comorbid disorder. Comorbid disorders are associated not only with other comorbid disorders, but also with sociodemographic factors, inpatient versus outpatient status, and lifetime number of depressive episodes. The influence of these variations on current comorbidity patterns among MDD patients needs to be taken account of in treatment facilities.

Integrity signals

Registry

Crossref · 10.4088/jcp.v63n0207

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Large-scale cohort studies have documented that clinical populations have interindividual variability with substantial heterogeneity in types of comorbidity and aetiological risk.

    “Large-scale cohort studies have documented that clinical populations have interindividual variability with substantial heterogeneity in types of comorbidity and aetiological risk (Lamers et al., 2010;Melartin et al., 2002;Sterling et al., 2008;Wessman et al., 2009).”

    From Meta-analysis of the effects of intranasal oxytocin on interpretation and expression of emotions (2017) · cites this paper as Melartin et al., 2002

  • Another possible interpretation of the present findings is that there is substantial heterogeneity within and between clinical groups that could dilute the true effects of intranasal oxytocin on social threat processing among clinical populations.

    “Another possible interpretation of the present findings is that there is substantial heterogeneity within and between clinical groups that could dilute the true effects of intranasal oxytocin on social threat processing among clinical populations (Lamers et al., 2010;Melartin et al., 2002;Wessman et al., 2009).”

    From Meta-analytic review of the effects of a single dose of intranasal oxytocin on threat processing in humans (2018) · cites this paper as Melartin et al., 2002

Cites

Still being checked.

Cited by

Sorted by citations

Related

Authors
Melartin, T. K., Rytsala, H. J., Leskela, U. S., Lestela-Mielonen, P. S., Sokero, T. P., & Isometsa, E. T.
Venue
The Journal of Clinical Psychiatry
Publisher
Physicians Postgraduate Press, Inc
Published
2002-02-15
Volume
63
Issue
2
Pages
126-134
ISSN
0160-6689 (ISSN-L)
DOI
10.4088/jcp.v63n0207
OpenAlex
W1967325475
Cited by
260
References
0
Citations by year
2026: 5 · 2025: 3 · 2024: 6 · 2023: 5 · 2022: 2 · 2021: 7 · 2020: 9 · 2019: 10 · 2018: 17 · 2017: 18 · 2016: 13 · 2015: 6 · 2014: 9 · 2013: 17 · 2012: 12
FWCI
13.25
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
  • Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
Keywords
major depressive disorder, psychiatric comorbidity, anxiety disorders, personality disorders, substance use disorders, alcoholism, panic disorder, agoraphobia, sociodemographic factors
MeSH terms
Adult, Age Factors, Ambulatory Care, Anxiety Disorders, Mental Disorders, Depressive Disorder, Female, Finland, Health Services Research, Hospitalization, Humans, Male, Personality Disorders, Psychiatric Status Rating Scales, Sex Factors, Comorbidity, Prevalence, Marital Status, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review